Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Brendan Kennedy, the head of one of the world's largest cannabis investment firms, says he's mostly seeing recycled business plans but believes the industry's next phase of startup innovation will be around everyday products sold by mainstream retailers.
Thesis: Kennedy says that Cannabis 1.0 related directly to the flower, while Cannabis 2.0 was about beverages. He believes Cannabis 3.0, which is just beginning, will be in all sorts of consumables (shampoos, lotions, cookies, etc.) that will sit alongside more "traditional" versions at places like Walgreens and Target.
- "Most major retailers will sell cannabinoid products, just as another sort of brand," he says. "There's an enormous amount of opportunity there for new companies."
Kennedy is the Seattle-based executive chairman of Privateer Holdings. He's also CEO of Tilray, the Canadian cannabis company whose stock has mellowed since its red-hot IPO.
What he's saying: Kennedy also was agnostic on the 2020 presidential election, even though most of the Democratic Party candidates support federal legalization, with the exception of Joe Biden.
- Kennedy is more concerned with legalization ballot initiatives in upwards of 7 "deep red" states. He believes if those states go legal, then it will put pressure on their GOP senators.
- He adds that some in his industry believe that President Trump may reverse his anti-legalization position before November 2020, in order to take that issue off the table, but Kennedy admits that may just be wishful thinking.